Understanding payer views of preventive care
Substantial research demonstrates that preventive care – including vaccination programs, services encouraging physical activity, and technologies such as...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
For 25 years, our global team of senior experts has helped Life Science firms anticipate trends and break through strategic barriers. CRA’s fit-for-purpose designs go beyond a single project, to build a true strategic partnership, providing cross-functional support across industry stakeholders and geographies. Clients rely on CRA’s institutional knowledge and subject matter expertise to provide an independent perspective to address core business issues, drive change, and align internal stakeholders.
We help clients address challenges in four key areas of strategy.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comSubstantial research demonstrates that preventive care – including vaccination programs, services encouraging physical activity, and technologies such as...
The regenerative medicine sector, comprised of tissue engineered products and cell and gene therapies, has grown rapidly over the past decade, including...
Lev Gerlovin is a speaker during the session titled “Assess Value When Innovating to Establish Greater Benefits Relative to Costs.” For more information on...
Ten of our consultants had four posters accepted and one of our consultants will host an on-demand podium presentation at this year’s virtual Congress. Price...